Clinical Trials Logo
  1. Home
  2. Unsafe Sex
  3. NCT03637322
  4. Details
NCT03637322 Clinical Trial

Evaluation of Implementation of the Phoenix PrEP (Pre-Exposure Prophylaxis) Access Project for Youth Aged 13-24

Unsafe Sex Clinical Trial

Official title:
Evaluation of Implementation of the Phoenix PrEP Access Project for Youth Aged 13-24

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03637322
Other study ID # 17-196
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2018
Est. completion date December 31, 2022

Study information
Verified date March 2023
Source Phoenix Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will evaluate the implementation of a PrEP program for youth aged 13-24 in Phoenix, AZ. Numbers of youth who initiate PrEP, how long they continue with PrEP, and the barriers for youth who are trying to initiate and continue taking PrEP will be examined.

Description:

This observational study will describe the barriers encountered and the benefits found as youth engage in a PrEP program, the Phoenix PrEP Access Project and as they participate in PrEP provided through standard medical care. This study does not investigate the safety, efficacy or other medical benefits of PrEP, but looks at the issues surrounding youth who are trying to access PrEP.

Recruitment information / eligibility
Status Completed
Enrollment 42
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 13 Years to 24 Years
Eligibility Inclusion Criteria - sexually active youth aged 13 through 24, - at risk for contracting HIV, - Negative for HIV as indicated by Negative Elisa and Western Blot (WB) or Negative 4th Generation test, - weight greater than 35kg, - offered PrEP to reduce the risk of contracting HIV. Exclusion Criteria - Unknown or Positive HIV status, - Renal Impairment as indicated by elevated BUN or Creatinine, abnormal urinalysis, - Active infection with Hepatitis B Virus, - Taking other medications containing Emtricitabine, Tenofovir or tenofovir alafenamide(TAF) such as Atripla, Complera, Emtriva, Genvoya, Odefsey, Stribild, and Viread taking drugs containing lamivudine, - taking Hepsera, - clinical symptoms consistent with acute viral infection within the past month.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Phoenix Children's Hospital, Bill Holt Clinic Phoenix Arizona

Sponsors (1)
Lead Sponsor Collaborator
Phoenix Children's Hospital

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary PrEP Uptake Uptake of PrEP offered to youth presenting for PrEP ages 13-24 3 years
See also
  Status Clinical Trial Phase
Completed NCT01907126 - HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence Phase 2
Completed NCT03980873 - Cognitive-Behavioral Therapy for Young Adult Lesbian, Gay and Bisexual: Transdiagnostic Minority Stress Approach N/A
Completed NCT02387489 - A Clinical Trial of SBIRT Services in School-based Health Centers N/A
Completed NCT01849029 - Cognitive Processing Intervention for Trauma, HIV/STI Risks, and Substance Use Among Native Women N/A
Completed NCT01499706 - Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older Adults Phase 1
Completed NCT01351389 - Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk N/A
Recruiting NCT03224416 - Individual and Contextual Factors That Influence Sexual Decisions N/A
Not yet recruiting NCT06435234 - Construction of a Risky Sexual Behaviour Intervention Programme for College Students Based on BCW Theory N/A
Completed NCT01690494 - Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders N/A
Completed NCT01376895 - Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W) Phase 1/Phase 2
Active, not recruiting NCT04597424 - Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP) Phase 3
Completed NCT02847858 - Health-E You: Reducing Unintended Pregnancies Among Hispanic Adolescents N/A
Completed NCT03961633 - AWARE Intervention: Feasibility and Efficacy Trial at Three University Health Services Centers N/A
Completed NCT01640392 - MyLife MyStyle Evaluation Project N/A